SEC Tracker
Get the app

GE HealthCare Technologies GEHC

GE HealthCare Technologies reports executive departure

Item 5.02 Executive or director change

Form
8-K
Filed
Importance
Major
  1. Taha Kass-Hout resigns as Chief Science and Technology Officer
  2. Last day of employment is December 31, 2026

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when GE HealthCare Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

The reading, claim by claim

  1. His last day at the company will be December 31, 2026, as stated in Item 5.02 of the filing.
  2. The report was signed by Frank R. Jimenez, General Counsel and Corporate Secretary.

2 of 2 claims matched the filing text.

For perspective, checked against its own source

From the 10-Q for the quarter ended September 30, 2026

  • For the quarter ended September 30, 2026, GE HealthCare Technologies Inc. reported revenue of $5.5 billion.
  • Revenue for the quarter increased by 7.2% compared to the same period a year earlier.

From the filing

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 4, 2026, Taha Kass-Hout notified GE HealthCare Technologies Inc. ("GE HealthCare") that he will resign as Chief Science and Technology Officer. Mr. Kass-Hout's last day at GE HealthCare will be December 31, 20261.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GE HealthCare Technologies Inc.

(Registrant)

Date: November 5, 2026

/s/ Frank R. Jimenez2

Frank R. Jimenez, General Counsel and Corporate Secretary2 (authorized signatory)

Similar companies

Companies of similar size in SIC 3844 and related industry codes: the same peer list as the financial tables.

  1. Dexcom DXCM public float $34.2B, Jun 30, 2025
  2. Resmed RMD public float $34.9B, Dec 31, 2025
  3. Edwards Lifesciences EW public float $45.9B, Jun 30, 2025
  4. STERIS STE public float $24.2B, Sep 30, 2025
  5. Insulet PODD public float $22.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.